Related references
Note: Only part of the references are listed.Quantitative-Structure-Activity-Relationship (QSAR) models for the reaction rate and temperature of nitrogenous organic compounds in supercritical water oxidation (SCWO)
Zhiwen Cheng et al.
CHEMICAL ENGINEERING JOURNAL (2018)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors
Somayeh Zare et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2017)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
Kinase Drug Discovery - What's Next in the Field?
Philip Cohen et al.
ACS CHEMICAL BIOLOGY (2013)
Design, synthesis, and biological evaluation of novel 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives as potent receptor tyrosine kinase inhibitors
Lei Ding et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors
Moon H. Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Axitinib In Advanced, Treatment-Experienced Renal Cell Carcinoma
Lily P. H. Yang et al.
DRUGS (2012)
Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors
Francesca Musumeci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques
Kunal Roy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
An overview of small-molecule inhibitors of VEGFR signaling
S. Percy Ivy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
The importance of the domain of applicability in QSAR modeling
Shane Weaver et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
L Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Receptor tyrosine kinases as target for anti-cancer therapy
S Brunelleschi et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Prediction of drug absorption using multivariate statistics
WJ Egan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Application of quantum chemical descriptor in quantitative structure activity and structure property relationship
P Thanikaivelan et al.
CHEMICAL PHYSICS LETTERS (2000)
Share Paper
